Currently Funded Project, Griffith University, Currently Funded Griffith

Contract Research Organisation Scoping

Working WithGriffith University
Lead ResearcherProf James St John
PCSRF funding period2023 - 2024
Total Funds Committed$88,000

A human clinical trial is a major undertaking as the cell product needs to meet strict regulations that are defined by the Australian Government. However, for a therapy to be successful it must also comply with international government regulations so that it can be delivered to countries around the world. 

This funding from PCSRF allowed the Spinal Injury Project team at Griffith University to engage international consultants who advised them on the various international regulations and requirements. With this information, the research team was able to focus their research to generate the required data that will need to be provided in future.

Having the confidence that the cell transplantation therapy is produced in accordance with international regulations enables to team to proceed to the Phase I/IIA human clinical trial. It also will give confidence to potential investors who will be needed to support the therapy as it moves into the larger Phase IIB and Phase III trials in future.

Interested in helping to raise funds

There are many ways you can help

Newsletter Signup


Sub heading here

Perry Cross Logo

Spinal Injury Project Research

Perry Cross Logo

LIVINWell Free Online Webinar

Register to receive your free gift
Perry Cross Logo Blk@2x

Leave a Gift in Your Will

A legacy gift to the Perry Cross Spinal Research Foundation will help us continue the journey to discover a cure for paralysis and its many complexities.

You can help people across the world to walk again. We can’t thank you enough for considering us.

Please contact us on
0457 277 579 for a confidential discussion.